Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 931-324-9 | CAS number: 866889-72-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 3 March 2011 to March 29, 2011.
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: EU Method and GLP study.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 011
- Report date:
- 2011
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 420 (Acute Oral Toxicity - Fixed Dose Method)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 bis (Acute Oral Toxicity - Fixed Dose Procedure)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- fixed dose procedure
- Limit test:
- yes
Test material
- Reference substance name:
- Amides, C12-14 (even numbered), N-[3-(dimethylamino) propyl], N'-oxides
- IUPAC Name:
- Amides, C12-14 (even numbered), N-[3-(dimethylamino) propyl], N'-oxides
- Details on test material:
- - Name of test material (as cited in study report): Amides, C12-14 (even numbered), N-[3-(dimethylamino) propyl], N'-oxides
- Physical state: clear colourless liquid
- Analytical purity: 33%
- Lot/batch No.: 264176.T0694
- Expiration date of the lot/batch: 3 September 2011
- Storage condition of test material: room temperature in the dark
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan Laboratories U.K. Ltd., Oxon, UK.
- Age at study initiation: 8-12 weeks
- Weight at study initiation: 180-186 g
- Fasting period before study: overnight fast immediately before dosing.
- Housing: in groups of up to four in suspended solid-flood polypropylene cages furnished with woodflakes.
- Diet (e.g. ad libitum): ad libitum (with the exception of the 3-4 hours fast period after dosing). 2014 Teklad Global Rodent diet.
- Water (e.g. ad libitum): ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19 to 25ºC
- Humidity (%): 30 to 70%
- Air changes (per hr): at least 15 changes / hour
- Photoperiod (hrs dark / hrs light): 12 h dark / 12 h light (06:00 to 18:00 h).
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- MAXIMUM DOSE VOLUME APPLIED:
6.13 ml/kg (6061 mg/kg bw dose level, equivalent to 2000 mg active ingredient/kg bw)
0.93 ml/kg (910 mg/kg bw dose level, equivalent to 300 mg active ingredient/kg bw) - Doses:
- 6061 mg/kg of the test item (equivalent to 2000 mg active ingredient/kg bw)
910 mg/kg of the test item (equivalent to 300 mg active ingredient/kg bw) - No. of animals per sex per dose:
- Group 1 (2000 mg active ingredient/kg bw): 1
Group 2 (300 mg active ingredient/kg bw): 5 - Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: clinical observations were made ½, 1, 2 and 4 hours after dosing and then daily for up to fourteen days. Morbidity and mortality checks were made twice daily. Individual bodyweights were recorded on Day 0 (the day of dosing) and on Days 7 and 14 or at death.
- Necropsy of survivors performed: yes, by cervical dislocation. This consisted of an external examination and opening of the abdominal and thoracic cavities. The appearance of any macroscopic abnormalities was recorded. No tissues were retained.
Results and discussion
Effect levels
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 910 - 6 061 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: Equivalent to 300-2000 mg active ingredient/kg bw
- Mortality:
- The animal treated at a dose level of 6061 mg/kg (equivalent to 2000 mg active ingredient/kg bw) was found dead one day after dosing. There were no deaths at a dose level of 910 mg/kg (equivalent to 300 mg active ingredient/kg bw).
- Clinical signs:
- other: Exophthalmos and hunched posture were noted in the animal treated at a dose level of 6061 mg/kg (equivalent to 2000 mg active ingredient/kg bw). Signs of systemic toxicity noted in the initial animal treated at a dose level of 910 mg/kg (equivalent to 300
- Gross pathology:
- Abnormalities noted at necropsy of the animal treated at a dose level of 6061 mg/kg (equivalent to 2000 mg active ingredient/kg bw), that died during the study, were dark liver, dark kidneys, gaseous distension and dark brown coloured liquid present in the stomach and haemorrhage of the gastric mucosa and non-glandular epithelium of the stomach. No abnormalities were noted at necropsy of animals that were killed at the end of the study.
Applicant's summary and conclusion
- Interpretation of results:
- Toxicity Category IV
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The LD50 of the test item in rats was estimated to be in the range of 910-6061 mg/kg bw (equivalent to 300-2000 mg active ingredient/kg bw).
- Executive summary:
The study was performed to assess the acute oral toxicity of the test item in the Wistar strain rat. The method was designed to be compatible with OECD Guideline 420 “Acute Oral Toxicity - Fixed Dose Method” and EU Method B1 bis Acute Toxicity (Oral).
Following a sighting test at dose levels of 6061 mg/kg and 910 mg/kg (equivalent to 2000 and 300 mg active ingredient/kg bw, respectively), a further group of four fasted females was given a single oral dose of test item at a dose level of 910 mg/kg bw (equivalent to 300 mg active ingredient/kg bw). Clinical signs and bodyweight development were monitored during the study. All animals were subjected to gross necropsy. The animal treated at a dose level of 6061 mg/kg (equivalent to 2000 mg active ingredient/kg bw) was found dead one day after dosing. There were no deaths at a dose level of 910 mg/kg (equivalent to 300 mg active ingredient/kg bw). The clinical observations noted were exophthalmos and hunched posture (at a dose of 6061 mg/kg (equivalent to 2000 mg active ingredient/kg bw)). Signs of systemic toxicity noted in the initial animal treated at a dose level of 910 mg/kg (equivalent to 300 mg active ingredient/kg bw) were hunched posture, noisy respiration and pilo-erection. No signs of systemic toxicity were noted in the additional four animals treated at a dose level of 910 mg/kg (equivalent to 300 mg active ingredient/kg bw). Surviving animals showed expected gains in bodyweight. Abnormalities were noted at necropsy of the animal treated at a dose level of 6061 mg/kg (equivalent to 2000 mg active ingredient/kg bw), that died during the study. No abnormalities were noted at necropsy of animals that were killed at the end of the study. The acute oral median lethal dose (LD50) of the test item in rat was estimated to be in the range 910-6061 mg/kg bw (equivalent to 300-2000 mg active ingredient/kg bw).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.